Tab. Midazolam is one of 53 small molecule programs targeting Nausea and vomiting. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
78 competitors in Nausea and Vomiting
Sufenta
Bridion
Naropin
Thalomid
Abraxane
Gemzar
Megace
Nereus
HSK21542
Adriamycin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details